From GlobeNewswire:

Zealand Pharma A/S will participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th, 2024. The President and CEO will be speaking at 10:10 a.m. ET (4:10 p.m. CET). A live audio webcast will be available for those who can’t attend. Zealand Pharma is a biotech company focused on developing peptide-based medicines, with several candidates in clinical development and two already on the market. For more information, visit www.zealandpharma.com. Contact Adam Lange for investor relations or Anna Krassowska for investors and media.



Read more: Zealand Pharma to participate in the Goldman Sachs